Neuraldrink™ — Circadian Functional Beverages
Sol™
Daytime Hydration + Performance
Luna™
Nighttime Hydration + Recovery
Sol™ — Daytime Hydration + Performance
Timing
Morning through Early Afternoon
Primary Targets
Hydration, ATP, Dopaminergic
Philosophy
“Clean energy that sustains”
Form
Powder → 16-20 oz water
Complete Formulation
Complete Formulation
Sol™ Ingredient Matrix
| Ingredient | Form | Dose | Primary Domain | Mechanism | Evidence Tier |
|---|---|---|---|---|---|
| Paraxanthine | enfinity® | 100 mg | Adenosine | A2A antagonism; clean alertness | TIER 2 |
| Creatine | Creapure® Monohydrate | 2,500 mg | ATP Systems | Phosphocreatine buffering; dissolves well | TIER 1 |
| L-Tyrosine | N-Acetyl-L-Tyrosine | 300 mg | Dopaminergic | DA/NE precursor; stress resilience | TIER 1 |
| Taurine | Pharmaceutical grade | 1,000 mg | Cellular, Osmoregulation | Cellular hydration; antioxidant | TIER 1 |
| Rhodiola Extract | 3% salidroside | 150 mg | HPA Axis | Adaptogenic; fatigue resistance | TIER 2 |
| Electrolyte Complex | — | — | Hydration | Optimal cellular hydration | TIER 1 |
| B-Vitamin Hydration Complex | Active forms | — | Energy, Methylation | Water-soluble; lost in sweat | TIER 1 |
Electrolyte Complex (per serving)
| Electrolyte | Form | Dose | Rationale |
|---|---|---|---|
| Sodium | Sodium Citrate + Pink Himalayan | 500 mg | Primary extracellular electrolyte; drives hydration |
| Potassium | Potassium Citrate | 300 mg | Intracellular balance; muscle function |
| Magnesium | Magnesium Citrate | 75 mg | Cofactor; often depleted; muscle relaxation |
| Chloride | From sodium chloride | 200 mg | Fluid balance; gastric function |
| Calcium | Calcium Citrate | 50 mg | Nerve transmission; muscle contraction |
B-Vitamin Hydration Complex (within Sol™)
| Vitamin | Form | Dose | Rationale |
|---|---|---|---|
| B1 | Thiamine HCl | 25 mg | Sweat loss replacement; energy |
| B2 | Riboflavin-5’-Phosphate | 10 mg | Energy metabolism |
| B3 | Niacinamide | 50 mg | NAD+ support |
| B5 | D-Calcium Pantothenate | 25 mg | CoA synthesis |
| B6 | Pyridoxal-5’-Phosphate | 10 mg | Amino acid metabolism |
| B12 | Methylcobalamin | 250 mcg | Energy; nerve function |
| Vitamin C | Ascorbic Acid | 100 mg | Antioxidant; enhances absorption |
Mechanism Integration
Usage Protocol
Usage Protocol
Optimal Use
| Parameter | Recommendation | Rationale |
|---|---|---|
| Timing | Morning or early afternoon | Paraxanthine needs 6+ hours before sleep |
| Frequency | 1-2 servings daily | Based on activity level and heat exposure |
| Mixing | 16-20 oz cold water | Dissolve fully before drinking |
| Pairs with | Boost™ (morning) or Sustain™ (midday) | Complementary, not redundant |
Activity-Based Dosing
| Scenario | Sol™ Protocol |
|---|---|
| Office work | 1 serving morning |
| Light exercise | 1 serving pre-workout |
| Intense exercise / heat | 1 serving pre, 1 serving during/post |
| Travel / dehydration | 1-2 servings as needed |
Flavor Options
| Flavor | Notes |
|---|---|
| Citrus Sunrise | Orange, lemon, hint of ginger |
| Tropical Focus | Mango, pineapple, coconut |
| Berry Charge | Mixed berry, light tartness |
Integration with All Systems Go™
Integration with All Systems Go™
Combination Protocol
| Time | All Systems Go™ | Neuraldrink™ | Notes |
|---|---|---|---|
| 6-7 AM | Boost™ | — | Foundation morning stack |
| 8-10 AM | — | Sol™ | Hydration + extended energy |
| 12-2 PM | Sustain™ | — | Midday cognitive support |
| 2-4 PM | — | Sol™ (optional) | If extended afternoon demands |
Synergy Analysis
| Combination | Effect | Caution |
|---|---|---|
| Sol™ + Boost™ | Comprehensive morning activation | Total paraxanthine stays at 100mg (safe) |
| Sol™ + Sustain™ | Total paraxanthine = 200mg | Maximum safe daily level; do not add ParaCaffeine +™ |
| Sol™ + ParaCaffeine +™ | 200mg paraxanthine | Safe but watch timing; no more than 2PM |
Luna™ — Nighttime Hydration + Recovery
Timing
Evening (1-2 hours before bed)
Primary Targets
Hydration, Circadian, GABAergic
Philosophy
“Hydrate while you restore”
Form
Powder → 12-16 oz water
Complete Formulation
Complete Formulation
Luna™ Ingredient Matrix
| Ingredient | Form | Dose | Primary Domain | Mechanism | Evidence Tier |
|---|---|---|---|---|---|
| Glycine | Pharmaceutical grade | 3,000 mg | Circadian | Thermoregulation (-0.3°C core temp) | TIER 1 |
| Magnesium | Magnesium Glycinate | 200 mg elemental | GABAergic | GABA potentiation; relaxation; additional glycine | TIER 1 |
| L-Theanine | Suntheanine® | 150 mg | GABAergic | Alpha waves; calm without sedation | TIER 1 |
| Taurine | Pharmaceutical grade | 500 mg | GABAergic | GABA-A agonist; inhibitory tone | TIER 2 |
| Apigenin | 98% extract | 25 mg | NAD+, GABAergic | CD38 inhibition; mild anxiolytic | TIER 2 |
| Electrolyte Complex (Night) | — | — | Hydration | Overnight hydration; reduced sodium | TIER 1 |
Electrolyte Complex — Night (per serving)
| Electrolyte | Form | Dose | Rationale |
|---|---|---|---|
| Sodium | Sodium Citrate | 200 mg | Lower than Sol™; prevents nighttime thirst/urination |
| Potassium | Potassium Citrate | 300 mg | Maintains intracellular balance |
| Magnesium | From Mag Glycinate above | (included) | Relaxation |
| Zinc | Zinc Picolinate | 10 mg | Sleep regulation; immune overnight |
Mechanism Integration
The Glycine-Thermoregulation Mechanism
The Glycine-Thermoregulation Mechanism
Why 3g Glycine is Essential
Glycine at 3g triggers a specific physiological cascade:| Clinical Evidence | Finding | Reference |
|---|---|---|
| Bannai et al. 2012 | 3g glycine reduced core body temperature and improved subjective sleep quality | Sleep Biol Rhythms |
| Kawai et al. 2015 | Glycine increased cutaneous blood flow, facilitating heat dissipation | Neuropsychopharmacology |
| Inagawa et al. 2006 | 3g glycine improved next-day alertness and reduced daytime fatigue | Sleep Biol Rhythms |
Why This Matters: Most sleep supplements target sedation (GABA, melatonin). Luna™ targets the thermoregulatory pathway — the body’s natural sleep-onset mechanism. This produces deeper, more restorative sleep without morning grogginess or dependence.
Usage Protocol
Usage Protocol
Optimal Use
| Parameter | Recommendation | Rationale |
|---|---|---|
| Timing | 30-90 minutes before bed | Allows thermoregulation to initiate |
| Mixing | 12-16 oz cool water | Smaller volume prevents nighttime urination |
| Temperature | Room temp or slightly cool | Hot liquid raises core temp (counterproductive) |
| Consistency | Nightly | Sleep architecture benefits compound |
Flavor Options
| Flavor | Notes |
|---|---|
| Lavender Calm | Light lavender, hint of vanilla |
| Chamomile Honey | Subtle sweetness, herbal notes |
| Unflavored | For those who prefer neutral; mixes into any beverage |
Integration with All Systems Go™
Integration with All Systems Go™
Combination Protocol
| Time | All Systems Go™ | Neuraldrink™ | Notes |
|---|---|---|---|
| 6-8 PM | Dinner | — | Allow digestion |
| 8-9 PM | — | Luna™ | Begin thermoregulation |
| 9-10 PM | Recover™ | — | Complete sleep stack |
| 10-11 PM | — | Sleep | Full protocol active |
Synergy with Recover™
| Ingredient | Recover™ | Luna™ | Combined Total | Notes |
|---|---|---|---|---|
| Glycine | 3,000 mg | 3,000 mg | 6,000 mg | Safe; enhanced thermoregulation |
| Magnesium | 244 mg | 200 mg | 444 mg | Optimal range; no excess |
| L-Theanine | 200 mg | 150 mg | 350 mg | Enhanced alpha waves |
| Taurine | 1,000 mg | 500 mg | 1,500 mg | Strong GABAergic tone |
| Apigenin | 50 mg | 25 mg | 75 mg | Robust CD38 inhibition |
ParaCaffeine +™ — Clean Stimulation
Timing
As Needed (before 2 PM)
Primary Targets
Adenosine, Dopaminergic
Philosophy
“Caffeine evolved — no jitters, no crash”
Form
Capsules (2)
Why Paraxanthine > Caffeine
Why Paraxanthine > Caffeine
Caffeine Metabolism
Comparative Pharmacology
| Property | Caffeine | Paraxanthine |
|---|---|---|
| A2A receptor affinity | 1× | 2.2× |
| Half-life | 5-6 hours | 3-4 hours |
| Anxiogenic metabolites | Yes (theophylline) | None |
| Sleep interference | High | Lower |
| Jitters/anxiety | Common | Rare |
| Tolerance development | Rapid | Slower |
| Crash | Common | Minimal |
Clinical Evidence
| Study | Design | N | Finding | Reference |
|---|---|---|---|---|
| Xing et al. 2021 | RCT, DB, PC | 11 | Paraxanthine improved sustained attention and reaction time | Nutrients |
| Yoo et al. 2021 | Acute pharmacology | — | Paraxanthine has higher A2A selectivity than caffeine | Psychopharmacology |
| Benowitz et al. 1995 | Pharmacokinetic | 10 | Paraxanthine clearance faster than caffeine | Clin Pharmacol Ther |
Complete Formulation
Complete Formulation
ParaCaffeine +™ Ingredient Matrix
| Ingredient | Form | Dose | Primary Domain | Mechanism | Evidence Tier |
|---|---|---|---|---|---|
| Paraxanthine | enfinity® | 100 mg | Adenosine | A2A antagonism; clean alertness | TIER 2 |
| L-Theanine | Suntheanine® | 200 mg | GABAergic | Smooths stimulation; alpha waves | TIER 1 |
| CDP-Choline | Cognizin® | 100 mg | Cholinergic | Sustains acetylcholine under stimulation | TIER 1 |
| L-Tyrosine | N-Acetyl-L-Tyrosine | 200 mg | Dopaminergic | Replenishes catecholamines | TIER 1 |
| Theobromine | Cacao-derived | 50 mg | Cardiovascular | Mild vasodilation; smooth energy curve | TIER 2 |
| B6 | Pyridoxal-5’-Phosphate | 10 mg | Methylation | Neurotransmitter synthesis cofactor | TIER 1 |
| B12 | Methylcobalamin | 250 mcg | Methylation | Energy; nerve function | TIER 1 |
Mechanism Integration
Why These Cofactors?
| Cofactor | Rationale |
|---|---|
| L-Theanine | Proven synergy with xanthines; promotes alpha waves; eliminates jitteriness |
| CDP-Choline | Stimulants deplete acetylcholine; CDP-Choline prevents this |
| L-Tyrosine | Stimulants deplete catecholamines; tyrosine replenishes |
| Theobromine (low dose) | Extends energy curve without caffeine’s downsides |
| B6, B12 | Neurotransmitter synthesis requires these cofactors |
Usage Protocol
Usage Protocol
Optimal Use
| Parameter | Recommendation | Rationale |
|---|---|---|
| Timing | Morning or early afternoon | Allow 6+ hours before sleep |
| Cutoff | 2 PM (strict) | Even with shorter half-life, evening use affects sleep |
| Frequency | As needed, not daily | Prevents tolerance; maintains sensitivity |
| Maximum | 2 servings (200mg paraxanthine) | Higher doses lose benefit/risk ratio |
Comparison to Coffee
| 1 Cup Coffee (~95mg caffeine) | ParaCaffeine +™ (100mg paraxanthine) |
|---|---|
| Mixed metabolites | Pure active compound |
| Jitters common | Jitters rare |
| 5-6 hour half-life | 3-4 hour half-life |
| Sleep disruption likely | Sleep-compatible (if before 2 PM) |
| Crash common | Crash minimal |
| Acidic, GI issues | Neutral, well-tolerated |
Integration with NTRPX
| Combination | Total Paraxanthine | Recommendation |
|---|---|---|
| ParaCaffeine +™ alone | 100 mg | Safe; ideal standalone |
| + Sustain™ | 200 mg | Safe; do not add Sol™ |
| + Sol™ | 200 mg | Safe; do not add Sustain™ |
| + Sustain™ + Sol™ | 300 mg | Maximum; use rarely |
Sprint™ — Acute Peak Performance
Timing
High-Demand Events Only
Primary Targets
Cholinergic MAX, Dopaminergic MAX
Philosophy
“Reserved for when you need peak output”
Form
Capsules (4-6)
Complete Formulation
Complete Formulation
Sprint™ Ingredient Matrix
| Ingredient | Form | Dose | Primary Domain | Mechanism | Evidence Tier |
|---|---|---|---|---|---|
| Alpha-GPC | 50% | 600 mg (300 mg Alpha-GPC) | Cholinergic | Rapid, high-bioavailability choline; crosses BBB | TIER 2 |
| Huperzine A | 1% extract | 200 mcg | Cholinergic | Acetylcholinesterase inhibitor; amplifies ACh | TIER 2 |
| Mucuna pruriens | 15% L-DOPA | 500 mg (75 mg L-DOPA) | Dopaminergic | Direct dopamine precursor; bypasses rate-limitation | TIER 2 |
| Caffeine Anhydrous | Pharmaceutical grade | 100 mg | Adenosine | Broader receptor profile than paraxanthine; acute power | TIER 1 |
| L-Theanine | Suntheanine® | 200 mg | GABAergic | Balances stimulation; prevents overshoot | TIER 1 |
| CDP-Choline | Cognizin® | 250 mg | Cholinergic | Additional choline; membrane support | TIER 1 |
| Phosphatidylserine | Sharp-PS® | 100 mg | Neuroprotection | Membrane; cortisol modulation under pressure | TIER 1 |
| Lion’s Mane | Fruiting body 8:1 | 500 mg | Neuroprotection | NGF support; neuroplasticity | TIER 2 |
| TTFD | Thiamine derivative | 50 mg | Mitochondrial | BBB-penetrant B1; cognitive energy | TIER 3 |
| B6 | Pyridoxal-5’-Phosphate | 25 mg | Dopaminergic | DOPA decarboxylase cofactor | TIER 1 |
| B12 | Methylcobalamin | 1,000 mcg | Methylation | Elevated for acute demand | TIER 1 |
Mechanism Integration
Why Caffeine Instead of Paraxanthine?
For Sprint™ specifically, caffeine is preferred:| Factor | Rationale |
|---|---|
| Broader receptor profile | Caffeine hits A1 and A2A; more complete adenosine blockade |
| Faster onset | Caffeine peaks faster for acute demands |
| Occasional use context | Sleep disruption less relevant for single-use scenarios |
| Synergy with L-DOPA | Traditional pairing with demonstrated effects |
Evidence Base
Evidence Base
Key Clinical Evidence
| Ingredient | Study | Design | N | Dose | Finding | Reference |
|---|---|---|---|---|---|---|
| Alpha-GPC | Parker et al. 2015 | RCT, DB, PC | 48 | 600mg | ↑ Lower body force production | J Int Soc Sports Nutr |
| Alpha-GPC | Bellar et al. 2015 | RCT | 13 | 600mg | ↑ Isometric strength | J Int Soc Sports Nutr |
| Huperzine A | Sun et al. 1999 | RCT, DB, PC | 103 | 200mcg BID | ↑ Memory in AD patients | Zhongguo Yao Li Xue Bao |
| Mucuna | Katzenschlager et al. 2004 | RCT | 8 PD patients | 30g (contains L-DOPA) | Comparable to L-DOPA/carbidopa | J Neurol Neurosurg Psychiatry |
| Caffeine + L-Theanine | Haskell et al. 2008 | RCT, DB, PC | 48 | 150mg + 250mg | ↑ Attention, task switching | Biol Psychol |
Usage Protocol
Usage Protocol
When to Use Sprint™
| ✅ Appropriate | ❌ Not Appropriate |
|---|---|
| Major presentation | Daily productivity |
| Final exam | Regular work tasks |
| Competition day | Catching up on sleep debt |
| Critical negotiation | Social events |
| Job interview | Routine exercise |
| Creative deadline | Ongoing projects |
Protocol
| Parameter | Recommendation | Rationale |
|---|---|---|
| Timing | 60-90 minutes before peak demand | Allows full onset |
| Frequency | 1-2× per week MAXIMUM | Prevents tolerance |
| Cycling | 2 weeks on, 1 week off if using weekly | Maintains efficacy |
| Sleep | Do not use after 12 PM | Caffeine + L-DOPA will disrupt sleep |
| Food | Light meal or empty stomach | Heavy food delays absorption |
What to Expect
| Timeframe | Effects |
|---|---|
| 30-60 min | Onset of alertness, focus sharpening |
| 60-180 min | Peak performance window |
| 3-5 hours | Gradual return to baseline |
| Post-event | May feel mentally tired (normal; used resources) |
Safety Considerations
Safety Considerations
Contraindications
| Condition | Recommendation |
|---|---|
| Cardiovascular disease | Avoid (caffeine, stimulation) |
| Anxiety disorders | Avoid (may exacerbate) |
| Pregnancy/nursing | Avoid |
| MAO inhibitor medications | Contraindicated (L-DOPA interaction) |
| Parkinson’s medications | Consult physician (L-DOPA overlap) |
| Glaucoma | Caution (cholinergic effects) |
Side Effect Management
| Potential Side Effect | Cause | Management |
|---|---|---|
| Overstimulation | Caffeine + L-DOPA | Reduce dose; add more L-theanine |
| Headache | Cholinergic excess | Ensure hydration; reduce next dose |
| GI upset | L-DOPA | Take with light food |
| Insomnia | Too late in day | Strict AM use only |
Complete Meta System Summary
Total System Architecture
Total System Architecture
All Products at a Glance
Usage Scenarios
Usage Scenarios
Protocol Options
| Goal | Protocol | Products |
|---|---|---|
| Basic optimization | Foundation only | All Systems Go™ (Boost → Sustain → Recover) |
| Enhanced hydration | Foundation + Beverages | All Systems Go™ + Sol™ + Luna™ |
| Caffeine replacement | Entry point | ParaCaffeine +™ |
| Sleep focus | Evening stack | Recover™ + Luna™ |
| Maximum daily | Complete circadian | Boost → Sol → Sustain → Luna → Recover |
| High-demand event | Acute performance | Sprint™ (replaces Boost that day) |
Sample Weekly Schedule
| Day | Morning | Midday | Evening | Notes |
|---|---|---|---|---|
| Monday | Boost + Sol | Sustain | Recover + Luna | Full protocol |
| Tuesday | Boost | Sustain + ParaCaffeine+ | Recover | Extra afternoon energy |
| Wednesday | Boost + Sol | Sustain | Recover + Luna | Full protocol |
| Thursday | Sprint | (ride effect) | Recover + Luna | Major presentation |
| Friday | Boost | Sustain | Recover | Standard day |
| Saturday | Sol only | — | Luna | Light weekend |
| Sunday | — | — | Luna | Rest day |
Quality Specifications
Quality Specifications
Ingredient Sourcing Standards
| Category | Standard | Verification |
|---|---|---|
| Branded ingredients | Use specified brands (Cognizin®, Suntheanine®, etc.) | CoA required |
| Generic ingredients | ≥98% purity pharmaceutical grade | Third-party testing |
| Botanical extracts | Standardized to active compounds | HPLC verification |
| Heavy metals | USP <232>/<233> limits | ICP-MS testing |
| Microbial | USP <2021> standards | Batch testing |
| Stability | 24-month shelf life | Accelerated stability data |
Manufacturing Standards
| Parameter | Requirement |
|---|---|
| Facility | cGMP-certified |
| Testing | Identity, potency, purity each batch |
| Encapsulation | Vegetarian capsules (HPMC) |
| Powder mixing | V-blender with validated homogeneity |
| Packaging | UV-protective bottles; desiccant included |
Document Control
| Version | Date | Author | Changes |
|---|---|---|---|
| 1.0 | 2026-01-24 | NTRPX R&D | Complete Meta System formulations |

